To demonstrate that follistatin treatment enhances the efficiency of nuclear transfer (SCNT), cell allocation and preimplantational development were determined in bovine SCNT embryos in the present study. Treatment of activated SCNT embryos with 10 ng/ml follistatin significantly increased the proportion of blastocyst development compared to untreated SCNT embryos. In addition, an increase in trophectoderm (TE) cell numbers and relatively higher proportion of TE cells to total cells were observed, but the number of inner cell mass (ICM) cell and total cell numbers were not changed (P < 0.05). No significant effect of other doses of follistatin was observed for the above endpoints. However, treatment with 1 and 10 ng/ml follistatin reduced the proportion of nuclear transfer blastocysts with an ICM ratio of > 60% relative to untreated nuclear transfer blastocysts at Day 7. No significant effect of follistatin treatment on proportions of nuclear transfer blastocysts with ICM ratio of 20-40% or 40-60% was observed. Taken together, these results suggested that follistatin can be used to increase developmental competence of SCNT embryos in terms of cell allocation, particularly TE cells, during preimplantation stages, subsequently enhancing placentation and birth of live offspring.
I. Introduction
Poor oocyte competence contributes to infertility in humans and livestock species. Two well-defined bovine models of oocyte competence are the prepubertal oocyte and time to first cleavage models. In Vitro produced bovine embryos from prepubertal animals show a modest reduction in blastocyst formation (Revel et al., 1995; Damiani et al., 1996) and transfer of in vitro (Khatir et al., 1998) and in vivo produced bovine embryos (Armstrong et al., 2001 ) derived from oocytes of prepubertal animals results in reduced pregnancy success. Furthermore, in relatively earlier cleaved bovine embryos (30h post fertilization), blastocyst development rates are higher, compared to late cleaved embryos (Plante et al., 1994; Lonergan et al., 1999) .
During the initial cleavage divisions post-fertilization, embryonic development is supported by maternal mRNAs and proteins synthesized and stored during oogenesis which are critical for the interval between fertilization and the maternal-embryonic transition when transcriptional activity of the embryonic genome becomes robust at the 8-16 cell stage in cattle (Telford et al., 1990; De Sousa et al., 1998) . Thus, time to first cleavage of early bovine embryos is likely significantly influenced by differences in oocyte derived mRNA and proteins. However, the cloning/nuclear transfer technology for propagation of valuable livestock species, generation of transgenic animals, therapeutic cloning and research purposes is currently limited by low efficiency. Thus, we need to embryos that develop to the blastocyst including the number of trophectoderm (TE) cells with higher developmental competence, leading to an increase in live births from embryos.
It has been reported that follistatin plays a functional role in regulation of early embryogenesis in bovine (Lee et al., 2009 ) Especially, follistatin supplementation in the culture medium increased time to first cleavage, proportion of blastocyst, and total and trophectoderm cell numbers of blastocyst. In the present study, we also used bovine model to test whether follistatin plays a functional role in somatic cell nuclear transfer embryo.
II. Materials and Methods

Chemicals and media
Unless otherwise stated, all chemicals used in the present study were purchased from Sigma-Aldrich 
Preparation of Oocytes, Maturation and Enucleation
Cumulus-oocyte complexes (COCs) were aspirated from small antral follicles of 2-7 mm in diameter using an 18-gauge needle and 60-70 mm Hg of negative pressure in bovine ovaries obtained at a local abattoir. After washing of COCs with H-HECM, only oocyte with more than 3-4 layers of intact and unexpanded cumulus cells were selected. A group of 50 COCs was introduced into 4-well dishes containing 400 ml of maturation medium, which had previously been equilibrated in an atmosphere of 5% CO 2 in air at 38.5°C for at least 2 h. The COCs were then cultured for 18 h at 38.5°C under the same atmospheric conditions. After maturation, cumulus cells were removed from the oocytes by 0.1% hyaluronidase treatment, and oocytes with extruded first polar bodies were selected for enucleation. The oocytes were stained with 0.5 mg/ml Hoechst 33342 in C4 medium for 20 min at 38.5°C, 5% CO 2 in air. All manipulation was performed in BO medium supplemented 7.5 mg/ml cytochalasin B. Both nuclei and polar body were removed by aspiration using an enucleation pipette. kV/cm). This was followed by incubation of NT embryos in C4 medium supplemented with 5 mg/ml cytochalasin B and 10 mg/ml cycloheximide for 6 h.
Somatic cell nuclear transfer
At the end of incubation, NT embryos were washed and transferred to culture medium. Untreated parthenogenetic embryos were included as quality control for oocytes. 
In vitro culture
The activated nuclear transfer and parthenogenic embryos were cultured in the presence or absence of 1, 10 and 100 ng/ml follistatin for initial 72 h. 
Differential staining of ICM and TE
The numbers of trophectoderm (TE) versus inner cell mass (ICM) cells and total cell numbers were determined by cell counts on differentially stained embryos. Briefly, the zonae pellucidae (ZP) of Day 7 blastocysts were removed by 0.5% pronase, and ZP-free blastocysts were washed in H-HECM. These blastocysts were then incubated in a 1:5 dilution of rabbit anti-pig whole serum (P-3164) for 1 h. After three times washing for each 5 min, the blastocysts were incubated in a 1:10 dilution of guinea pig complement (S-1639) for 1 h. A final concentration of 10 mg/ml propidium iodide (PI) was added to the complement solution. After washing again in H-HECM, they were mounted between slide glass and cover glass, and examined under Nikon inverted microscope using UV light. Total number of blastocysts introduced for differential staining was 22, 17, 23, 26 and 15 for parthenote, untreated control, 1, 10 and 100 ng/ml follistatin, respectively.
Statistical analysis
Data were analyzed using one-way ANOVA. For the embryos culture experiments, data were subjected to an arc-sin transformation, and the transformed values were analyzed using one-way ANOVA. When ANOVA revealed a significant effect, the treatments were compared by Fisher's Protected Least Significant Difference (PLSD) test.
III. Results
To demonstrate that follistatin treatment enhances the efficiency of nuclear transfer, the effects of follistatin supplementation on cell allocation and blastocyst development of nuclear transfer embryos was determined.
Due to defects in placentation and blastocyst cell allocation characteristic of SCNT embryos (presumably leading to high rates of pregnancy loss), this experiment was conducted to determine the effects of follistatin supplementation on development of SCNT (Fig. 2) . No significant effect of other doses of follistatin was observed for the above endpoints.
However, treatment with 1 and 10 ng/ml follistatin reduced the proportion of day 7 nuclear transfer blastocysts with an ICM ratio of ＞ 60% relative to untreated nuclear transfer blastocysts (Fig. 3) . No significant effect of follistatin treatment on proportions of d 7 nuclear transfer blastocysts with ICM ratio of 20-40% or 40-60% was observed (Fig. 4) .
IV. Discussion
It was previously demonstrated that follistatin is a marker of egg quality in cattle (Lee et al., 2009) .
The effects of endogenous follistatin on early embryonic development of in vitro fertilized bovine embryos were examined and stimulatory effects on development to the blastocyst stage and number of TE cells/ embryo quality were observed. TE cells combine with the ICM-derived ectraembryonic membranes to form the fetal placenta after pregnancy. Both ICM and TE cell lineages are essential for embryonic and fetal survival (Hardy et al., 1989) as well as embryo quality (Goo et al., 2002) . Given the stimulatory effects on blastocyst development and embryo quality (TE cells) observed and the observation that the number of TE cells and quality of nuclear transfer embryos is believed responsible for the less than 5% efficiency of generation of lives offspring, the effects of follistatin on development of nuclear transfer embryos to the blastocyst stage and numbers of TE cells in such embryos was examined.
In the present study, follistatin can enhance the proportion of blastocysts with ICM ratio of 20-40% even though there are no significant differences compared to control. It has been reported that embryos with ICM ratio of 20-40% are presumed to be higher quality because ＞80% of in vivo-derived blastocysts were classified into this category in previous studies (Goo et al., 2002) . Our result suggests that follistatin can increase the quality of in vitro produced blastocyst. 
